Cargando…
Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung
BACKGROUND: Targeted therapies based on the molecular and histological features of cancer types are becoming standard practice. The most effective regimen in lung cancers is different between squamous cell carcinoma (SCC) and adenocarcinoma (AD). Therefore a precise diagnosis is crucial, but this ha...
Autores principales: | Takamochi, Kazuya, Ohmiya, Hiroko, Itoh, Masayoshi, Mogushi, Kaoru, Saito, Tsuyoshi, Hara, Kieko, Mitani, Keiko, Kogo, Yasushi, Yamanaka, Yasunari, Kawai, Jun, Hayashizaki, Yoshihide, Oh, Shiaki, Suzuki, Kenji, Kawaji, Hideya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041559/ https://www.ncbi.nlm.nih.gov/pubmed/27681076 http://dx.doi.org/10.1186/s12885-016-2792-1 |
Ejemplares similares
-
Correlation of EGFR or KRAS mutation status with (18)F-FDG uptake on PET-CT scan in lung adenocarcinoma
por: Takamochi, Kazuya, et al.
Publicado: (2017) -
Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis
por: Yoshida, Emiko, et al.
Publicado: (2017) -
Correction: Discovery of Molecular Markers to Discriminate Corneal Endothelial Cells in the Human Body
por: Yoshihara, Masahito, et al.
Publicado: (2015) -
Discovery of Molecular Markers to Discriminate Corneal Endothelial Cells in the Human Body
por: Yoshihara, Masahito, et al.
Publicado: (2015) -
Galectin-4, a Novel Predictor for Lymph Node Metastasis in Lung Adenocarcinoma
por: Hayashi, Takuo, et al.
Publicado: (2013)